|
๐
|
Detection of Celiac Disease in Primary Care: A Multicenter Case-Finding Study in North America
15 auth.
C. Catassi,
D. Kryszak,
O. Louis-Jacques,
D. Duerksen,
I. Hill,
S. Crowe,
Andrew R. Brown,
N. Procaccini,
Brigid A Wonderly,
P. Hartley,
...
James Moreci,
Nathan L. Bennett,
K. Horvรกth,
M. Burk,
A. Fasano
|
8 |
2007 |
8
๐
|
|
๐
|
Risankizumab versus Ustekinumab for ModerateโtoโSevere Plaque Psoriasis
17 auth.
K. Papp,
A. Blauvelt,
M. Bukhalo,
M. Gooderham,
J. Krueger,
J. Lacour,
A. Menter,
S. Philipp,
H. Sofen,
S. Tyring,
...
B. Berner,
S. Visvanathan,
Chandrasena R Pamulapati,
Nathan L. Bennett,
M. Flack,
P. Scholl,
S. Padula
|
8 |
2017 |
8
๐
|
|
๐
|
Tiotropium + olodaterol shows clinically meaningful improvements in quality of life.
9 auth.
Dave Singh,
G. Ferguson,
J. Bolitschek,
L. Grรถnke,
C. Hallmann,
Nathan L. Bennett,
...
R. Abrahams,
O. Schmidt,
L. Bjermer
|
7 |
2015 |
7
๐
|
|
๐
|
Vibegron (RVT-901/MK-4618/KRP-114V) Administered Once Daily as Monotherapy or Concomitantly with Tolterodine in Patients with an Overactive Bladder: A Multicenter, Phase IIb, Randomized, Double-blind, Controlled Trial.
9 auth.
H. Mitcheson,
S. Samanta,
Karen Muldowney,
C. Pinto,
Beatriz de A Rocha,
S. Green,
...
Nathan L. Bennett,
P. Mudd,
T. Frenkl
|
5 |
2019 |
5
๐
|
|
๐
|
Migraine Patients With Cardiovascular Disease and Contraindications: An Analysis of Real-World Claims Data
12 auth.
D. Dodick,
Anand R Shewale,
R. Lipton,
S. Baum,
S. Marcus,
S. Silberstein,
...
J. Pavloviฤ,
Nathan L. Bennett,
W. Young,
H. Viswanathan,
J. Doshi,
Howard S. Weintraub
|
5 |
2020 |
5
๐
|
|
๐
|
Headache characteristics and burden from chronic migraine with medication overuse headache: Crossโsectional observations from the Medication Overuse Treatment Strategy trial
13 auth.
T. Schwedt,
J. Hentz,
S. Sahai-Srivastava,
Nicole Spare,
V. Martin,
Christina Treppendahl,
K. Digre,
Nathan L. Bennett,
Marius Birlea,
David Watson,
...
N. Murinova,
Teri Robert,
D. Dodick
|
5 |
2021 |
5
๐
|
|
๐
|
Effect of tiotropium and olodaterol on symptoms and patient-reported outcomes in patients with COPD: results from four randomised, double-blind studies
7 auth.
G. Ferguson,
J. Karpel,
Nathan L. Bennett,
E. Clerisme-Beaty,
L. Grรถnke,
F. Voร,
...
R. Buhl
|
4 |
2017 |
4
๐
|
|
๐
|
Ubrogepant for the Acute Treatment of Migraine: Pooled Efficacy, Safety, and Tolerability From the ACHIEVE I and ACHIEVE II Phase 3 Randomized Trials
7 auth.
Susan Hutchinson,
D. Dodick,
Christina Treppendahl,
Nathan L. Bennett,
S. Yu,
Hua Guo,
...
Joel M. Trugman
|
4 |
2021 |
4
๐
|
|
๐
|
Immunologic non-inferiority of a newly licensed inactivated trivalent influenza vaccine versus an established vaccine
8 auth.
J. Campbell,
C. Chambers,
R. Brady,
M. Caldwell,
Nathan L. Bennett,
M. Fourneau,
...
Varsha K. Jain,
B. Innis
|
3 |
2011 |
3
๐
|
